Liberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic Patients: The Transfusion Requirements in Critically Ill Oncologic Patients Randomized Controlled Trial

Imagem de Miniatura
Arquivos
art_BERGAMIN_Liberal_Versus_Restrictive_Transfusion_Strategy_in_Critically_Ill_2017.PDF (187.67 KB)
Citações na Scopus
71
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
LANDONI, Giovanni
FOMINSKIY, Evgeny
Citação
CRITICAL CARE MEDICINE, v.45, n.5, p.766-773, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To assess whether a restrictive strategy of RBC transfusion reduces 28-day mortality when compared with a liberal strategy in cancer patients with septic shock. Design: Single center, randomized, double-blind controlled trial. Setting: Teaching hospital. Patients: Adult cancer patients with septic shock in the first 6 hours of ICU admission. Interventions: Patients were randomized to the liberal (hemoglobin threshold, < 9 g/dL) or to the restrictive strategy (hemoglobin threshold, < 7 g/dL) of RBC transfusion during ICU stay. Measurements and Main Results: Patients were randomized to the liberal (n = 149) or to the restrictive transfusion strategy (n = 151) group. Patients in the liberal group received more RBC units than patients in the restrictive group (1 [0-3] vs 0 [0-2] unit; p<0.001). At 28 days after randomization, mortality rate in the liberal group (primary endpoint of the study) was 45% (67 patients) versus 56% (84 patients) in the restrictive group (hazard ratio, 0.74; 95% CI, 0.53-1.04; p = 0.08) with no differences in ICU and hospital length of stay. At 90 days after randomization, mortality rate in the liberal group was lower (59% vs 70%) than in the restrictive group (hazard ratio, 0.72; 95% CI, 0.53-0.97; p = 0.03). Conclusions: We observed a survival trend favoring a liberal transfusion strategy in patients with septic shock when compared with the restrictive strategy. These results went in the opposite direction of the a priori hypothesis and of other trials in the field and need to be confirmed.
Palavras-chave
critically ill oncology, intensive care, randomized controlled trial, transfusion
URI
https://observatorio.fm.usp.br/handle/OPI/19904
Referências
  1. Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853
  2. Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452
  3. Carson JL, 2012, COCHRANE DB SYST REV, V4, DOI 10.1002/14651858.CD002042.PUB3
  4. Chatterjee S, 2013, JAMA INTERN MED, V173, P132, DOI 10.1001/2013.jamainternmed.1001
  5. Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.00001104112.34142.79
  6. Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432
  7. de Almeida JP, 2015, ANESTHESIOLOGY, V122, P29, DOI 10.1097/ALN.0000000000000511
  8. de Montmollin E, 2013, SHOCK, V39, P250, DOI 10.1097/SHK.0b013e3182866d32
  9. Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af
  10. Gregersen M, 2015, ACTA ORTHOP, V86, P363, DOI 10.3109/17453674.2015.1006980
  11. Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601
  12. Hoist LB, 2014, NEW ENGL J MED, V371, P1381
  13. Hoist LB, 2015, BMJ-BRIT MED J, V350, ph1354, DOI 10.1136/BMJ.H1354
  14. Hovaguimian F, 2016, ANESTHESIOLOGY, V125, P46, DOI 10.1097/ALN.0000000000001162
  15. Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B
  16. Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372
  17. Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612
  18. Najjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559
  19. Park DW, 2012, CRIT CARE MED, V40, P3140, DOI 10.1097/CCM.0b013e3182657b75
  20. Pene F, 2008, CRIT CARE MED, V36, P690, DOI [10.1097/CCM.0B013E318165314B, 10.1097/CCM.OB013E318165314B]
  21. Regazzoni CJ, 2004, SUPPORT CARE CANCER, V12, P833, DOI 10.1007/s00520-004-0667-5
  22. Ridgeon EE, 2016, CRIT CARE MED, V44, P1278, DOI 10.1097/CCM.0000000000001670
  23. Rosolem MM, 2012, J CRIT CARE, V27, P301, DOI 10.1016/j.jcrc.2011.06.014
  24. Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
  25. Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e
  26. Staudinger Thomas, 2014, Rev. bras. ter. intensiva, V26, P335, DOI 10.5935/0103-507X.20140051
  27. Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801
  28. Vincent JL, 2008, ANESTHESIOLOGY, V108, P31
  29. Vincent JL, 2012, ANN INTERN MED, V157, P71, DOI [10.7326/0003-4819-157-1-201206190-00431, 10.7326/0003-4819-156-12-201206190-00431]
  30. Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Carregar mais